Regulatory & Legal

A new device debuting at CES 2026 uses nerve stimulation to treat the entire menstrual experience, not just cramps. Is this the future of femtech?

An industry-led program aims to launch low-cost converter boxes by 2026, ensuring millions aren't left behind in the broadcast TV transition.

Amid a crucial patent appeal and a competitive market, Scilex Holding hires renowned trial lawyer Marc Kasowitz, signaling an aggressive new legal strategy.

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

StickIt Technologies bets on a complex share consolidation and capital raise to survive, but are the terms a red flag for its investors and future?

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Smart cart maker A2Z Cust2Mate pivots for hyper-growth as its visionary founder exits, leaving the CEO as interim chair to steer a global expansion strategy.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

BitVentures diversifies into crypto, acquiring a 0.5 MW fleet of next-gen miners. Can its efficiency-focused strategy succeed in the competitive space?

Amidst a market downturn, CNH brings in leaders from Rivian and Nikola to spearhead its ambitious transformation in autonomy, AI, and global operations.

Michelin is acquiring Cooley Group and Tex Tech Industries, pushing deeper into advanced materials for aerospace and healthcare as part of its 2030 strategy.

Cambodia's landmark decision to recognize Cambridge AS/A Levels creates new university pathways for students and sets a bold precedent for Southeast Asia.

Samsung Bioepis is now directly selling its Lucentis biosimilar in Europe, a move set to increase competition and improve access to vital eye disease treatments.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

A fatal head-on train collision near Machu Picchu leaves one dead and dozens injured, triggering a massive tourist rescue operation by Peruvian authorities.

World No.1 table tennis star Sun Yingsha joins La Roche-Posay in a strategic play for Gen-Z hearts and the massive Asian beauty market.

A new white paper alleges many botanical supplements lack active ingredients. Is the industry ready for a scientific overhaul to prove what's in the bottle?

Insurtech firm PolicyStreet launches its largest promo yet, offering deep discounts and flexible payments to challenge traditional insurers in Malaysia.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.